Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full. More 

3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)

Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA). More 

10 Pharmaceuticals Stocks to Buy Now

10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

FDA Issues Warning on Hepatitis C Drugs

The Food and Drug Administration (FDA) has issued a warning surrounding several Hepatitis C drugs such as Sovaldi, Harvoni and Gilead Sciences. More 

How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)

A study of analyst recommendations shows that Merck & Co., Inc is the #12 broker pick out of the 30 stocks making up the Dow Jones More 

11 Pharmaceuticals Stocks to Buy Now

The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

9 Dividend Stocks for a Full Calendar of Safe Income

Build a secure monthly income stream by targeting these nine blue-chip dividend stocks that offer substantial yield. More